Superantigens of a superbug: Major culprits of Staphylococcus aureus disease?

References

• Lowy FD. Staphylococcus aureus infections. N Engl J Med 1998; 339:520-32; PMID:9709046; http://dx.doi.org/10.1056/NEJM199808203390806
   PubMed Web of Science ®Google Scholar
• Fowler VG, Jr, Proctor RA. Where does a Staphylococcus aureus vaccine stand? Clin Microbiol Infect 2014; 20 Suppl 5:66-75; PMID:24476315; http://dx.doi.org/10.1111/1469-0691.12570
   PubMed Web of Science ®Google Scholar
• Patel M, Kaufman DA. Anti-lipoteichoic acid monoclonal antibody (pagibaximab) studies for the prevention of staphylococcal bloodstream infections in preterm infants. Expert Opin Biol Ther 2015; 15:595-600; PMID:25736524; http://dx.doi.org/10.1517/14712598.2015.1019857
   PubMed Web of Science ®Google Scholar
• DeJonge M, Burchfield D, Bloom B, Duenas M, Walker W, Polak M, Jung E, Millard D, Schelonka R, Eyal F, et al. Clinical trial of safety and efficacy of INH-A21 for the prevention of nosocomial staphylococcal bloodstream infection in premature infants. J Pediatr 2007; 151:260-5; PMID:17719934; http://dx.doi.org/10.1016/j.jpeds.2007.04.060
   PubMed Web of Science ®Google Scholar
• Fowler VG, Allen KB, Moreira ED, Moustafa M, Isgro F, Boucher HW, Corey GR, Carmeli Y, Betts R, Hartzel JS, et al. Effect of an investigational vaccine for preventing Staphylococcus aureus infections after cardiothoracic surgery: a randomized trial. JAMA 2013; 309:1368-78; PMID:23549582; http://dx.doi.org/10.1001/jama.2013.3010
   PubMed Web of Science ®Google Scholar
• Spaulding AR, Salgado-Pabon W, Merriman JA, Stach CS, Ji Y, Gillman AN, Peterson ML, Schlievert PM. Vaccination Against Staphylococcus aureus Pneumonia. J Infect Dis 2014; 209:1955-62
   PubMed Web of Science ®Google Scholar
• Fraser JD, Proft T. The bacterial superantigen and superantigen-like proteins. Immunol Rev 2008; 225:226-43; PMID:18837785; http://dx.doi.org/10.1111/j.1600-065X.2008.00681.x
   PubMed Web of Science ®Google Scholar
• Hu DL, Nakane A. Mechanisms of staphylococcal enterotoxin-induced emesis. Eur J Pharmacol 2014; 722:95-107; PMID:24184671; http://dx.doi.org/10.1016/j.ejphar.2013.08.050
   PubMed Web of Science ®Google Scholar
• Varshney AK, Wang X, Scharff MD, Macintyre J, Zollner RS, Kovalenko OV, Martinez LR, Byrne FR, Fries BC. Staphylococcal Enterotoxin B-Specific Monoclonal Antibody 20B1 Successfully Treats Diverse Staphylococcus aureus Infections. J Infect Dis 2013; 208:2058-66; PMID:23922375
   PubMed Web of Science ®Google Scholar
• Nilsson IM, Lee JC, Bremell T, Ryden C, Tarkowski A. The role of staphylococcal polysaccharide microcapsule expression in septicemia and septic arthritis. Infect Immun 1997; 65:4216-21; PMID:9317029.
   PubMed Web of Science ®Google Scholar
• Hu DL, Omoe K, Sasaki S, Sashinami H, Sakuraba H, Yokomizo Y, Shinagawa K, Nakane A. Vaccination with nontoxic mutant toxic shock syndrome toxin 1 protects against Staphylococcus aureus infection. J Infect Dis 2003; 188:743-52; PMID:12934191; http://dx.doi.org/10.1086/377308
   PubMed Web of Science ®Google Scholar
• Mattis DM, Spaulding AR, Chuang-Smith ON, Sundberg EJ, Schlievert PM, Kranz DM. Engineering a soluble high-affinity receptor domain that neutralizes staphylococcal enterotoxin C in rabbit models of disease. Protein Eng Des Sel 2013; 26:133-42; PMID:23161916; http://dx.doi.org/10.1093/protein/gzs094
   PubMed Web of Science ®Google Scholar
• Aguilar JL, Varshney AK, Pechuan X, Dutta K, Nosanchuk JD, Fries BC. Monoclonal antibodies protect from Staphylococcal Enterotoxin K (SEK) induced toxic shock and sepsis by USA300 Staphylococcus aureus. Virulence 2016; 1-10; PMID:27715466
   PubMedGoogle Scholar
• David MZ, Daum RS. Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clin Microbiol Rev 2010; 23:616-87; PMID:20610826; http://dx.doi.org/10.1128/CMR.00081-09
   PubMed Web of Science ®Google Scholar
• Vandenesch F, Naimi T, Enright MC, Lina G, Nimmo GR, Heffernan H, Liassine N, Bes M, Greenland T, Reverdy ME, et al. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis 2003; 9:978-84; PMID:12967497; http://dx.doi.org/10.3201/eid0908.030089
   PubMed Web of Science ®Google Scholar
• Aguilar JL, Varshney AK, Wang X, Stanford L, Scharff M, Fries BC. Detection and measurement of staphylococcal enterotoxin-like K (SEl-K) secretion by Staphylococcus aureus clinical isolates. J Clin Microbiol 2014; 52:2536-43; PMID:24808237; http://dx.doi.org/10.1128/JCM.00387-14
   PubMed Web of Science ®Google Scholar
• Varshney AK, Mediavilla JR, Robiou N, Guh A, Wang X, Gialanella P, Levi MH, Kreiswirth BN, Fries BC. Diverse enterotoxin gene profiles among clonal complexes of Staphylococcus aureus isolates from the Bronx, New York. Appl Environ Microbiol 2009; 75:6839-49; PMID:19749060; http://dx.doi.org/10.1128/AEM.00272-09
   PubMed Web of Science ®Google Scholar
• Asensi GF, de Sales NF, Dutra FF, Feijo DF, Bozza MT, Ulrich RG, Miyoshi A, de Morais K, Azevedo VA, Silva JT, et al. Oral immunization with Lactococcus lactis secreting attenuated recombinant staphylococcal enterotoxin B induces a protective immune response in a murine model. Microb Cell Fact 2013; 12:32; PMID:23561053; http://dx.doi.org/10.1186/1475-2859-12-32
   PubMed Web of Science ®Google Scholar
• Hu DL, Omoe K, Narita K, Cui JC, Shinagawa K, Nakane A. Intranasal vaccination with a double mutant of staphylococcal enterotoxin C provides protection against Staphylococcus aureus infection. Microbes Infect 2006; 8:2841-8; PMID:17090392; http://dx.doi.org/10.1016/j.micinf.2006.09.001
   PubMed Web of Science ®Google Scholar
• Rajagopalan G, Sen MM, Singh M, Murali NS, Nath KA, Iijima K, Kita H, Leontovich AA, Gopinathan U, Patel R, et al. Intranasal exposure to staphylococcal enterotoxin B elicits an acute systemic inflammatory response. Shock 2006; 25:647-56; PMID:16721274; http://dx.doi.org/10.1097/01.shk.0000209565.92445.7d
   PubMed Web of Science ®Google Scholar
• Diep BA, Le VT, Visram ZC, Rouha H, Stulik L, Dip EC, Nagy G, Nagy E. Improved Protection in a Rabbit Model of Community-Associated Methicillin-Resistant Staphylococcus aureus Necrotizing Pneumonia upon Neutralization of Leukocidins in Addition to Alpha-Hemolysin. Antimicrob Agents Chemother 2016; 60:6333-40; PMID:27527081; http://dx.doi.org/10.1128/AAC.01213-16
   PubMed Web of Science ®Google Scholar
• Salgado-Pabon W, Breshears L, Spaulding AR, Merriman JA, Stach CS, Horswill AR, Peterson ML, Schlievert PM. Superantigens are critical for Staphylococcus aureus Infective endocarditis, sepsis, and acute kidney injury. MBio 2013; 4:e00494-13; PMID:23963178; http://dx.doi.org/10.1128/mBio.00494-13
   PubMed Web of Science ®Google Scholar
• Nienaber JJ, Sharma Kuinkel BK, Clarke-Pearson M, Lamlertthon S, Park L, Rude TH, Barriere S, Woods CW, Chu VH, Marín M, et al. Methicillin-susceptible Staphylococcus aureus endocarditis isolates are associated with clonal complex 30 genotype and a distinct repertoire of enterotoxins and adhesins. J Infect Dis 2011; 204:704-13; PMID:21844296; http://dx.doi.org/10.1093/infdis/jir389
   PubMed Web of Science ®Google Scholar
• Vandenesch F, Lina G, Henry T. Staphylococcus aureus hemolysins, bi-component leukocidins, and cytolytic peptides: a redundant arsenal of membrane-damaging virulence factors? Front Cell Infect Microbiol 2012; 2:12; PMID:22919604; http://dx.doi.org/10.3389/fcimb.2012.00012
   PubMed Web of Science ®Google Scholar
• Narita K, Hu DL, Asano K, Nakane A. Vaccination with non-toxic mutant toxic shock syndrome toxin-1 induces IL-17-dependent protection against Staphylococcus aureus infection. Pathog Dis 2015; 73: 00399-16; PMID:25857736; http://dx.doi.org/10.1093/femspd/ftv023
   PubMed Web of Science ®Google Scholar
• Chen WH, Pasetti MF, Adhikari RP, Baughman H, Douglas R, El-Khorazaty J, Greenberg N, Holtsberg FW, Liao GC, Reymann MK, et al. The safety and immunogenicity of a parenterally administered structure-based rationally modified recombinant Staphylococcal enterotoxin B protein vaccine, STEBVax. Clin Vaccine Immunol 2016; 6(9); 1036-44
   Web of Science ®Google Scholar
• Schwameis M, Roppenser B, Firbas C, Gruener CS, Model N, Stich N, Roetzer A, Buchtele N, Jilma B, Eibl MM. Safety, tolerability, and immunogenicity of a recombinant toxic shock syndrome toxin (rTSST)-1 variant vaccine: a randomised, double-blind, adjuvant-controlled, dose escalation first-in-man trial. Lancet Infect Dis 2016; 16:1036-44; PMID:27296693; http://dx.doi.org/10.1016/S1473-3099(16)30115-3
   PubMed Web of Science ®Google Scholar